drugset / Trial / NCT07709442
Songling Xuemaikang in Hypertension and Insomnia Evaluation（SHINE）
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the effect of Songling Xuemaikang Capsules on reducing 24-hour mean blood pressure in patients with hypertension accompanied by insomnia.
Timeline
- Start
- 2026-06-30
- Primary completion
- 2027-06-30
- Completion
- 2028-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Songling Xuemaikang Capsule | Unknown | 3 unknown | — |